Related Articles
Second-line chemotherapy with combined irinotecan and low-dose cisplatin for patients with metastatic gastric carcinoma resistant to 5-fluorouracil
Multicenter phase II study of fractionated bimonthly oxaliplatin with leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer, pre-treated with chemotherapy
Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapy
Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo Clinic regimen in the first-line therapy of advanced colorectal cancer
A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer